We report three cases of patients in their eighties who received anti-EGFR antibody mono-therapy as first-line treatment for metastatic colorectal cancer. CASE 1: An 86-year-old woman who received cetuximab after a colostomy for unresectable rectal cancer with synchronous liver and lung metastases. Serum levels of CEA and CA19-9 showed a significant decrease at 2 months, after which they showed a gradual increase.
View Article and Find Full Text PDFCetuximab (Erbitux) is a targeted therapy that used to treat metastatic colorectal cancer. It is classified as a "monoclonal antibody" and "signal transduction inhibitor" by binding to epidermal growth factor receptors (EGFR). We report 6 patients who responded well to cetuximab out of 8 patients with recurrent/advanced colorectal cancer who have received the drug at our hospital since November 2008.
View Article and Find Full Text PDFA 37-year-old male with locally advanced rectal carcinoma and liver metastasis was treated by multimodal therapy. Since he had severe anemia and perineal abscess, sigmoid colostomy was constructed. After his general condition was recovered, the patient received systemic chemotherapy with mFOLFOX6 (6 courses) and whole pelvic irradiation (40 Gy).
View Article and Find Full Text PDFA 68-year-old woman underwent distal gastrectomy for gastric cancer in February 2003. The Histological type was poorly differentiated adenocarcinoma, and the final finding was T3 (se, INF gamma, ly1, v0), pN1, sH0, sP0, pCY0; fStage IIIA. Two years and 5 months after the operation, a painless tumor was noticed on the upper abdomen.
View Article and Find Full Text PDFGan To Kagaku Ryoho
November 2006
A 63-year-old woman was admitted to the hospital for investigation of abdominal discomfort. Further examination revealed that she had sigmoid colon cancer. The serum CEA level was 20.
View Article and Find Full Text PDFUnlabelled: Radio-frequency ablation therapy (RFA) as a treatment for metastatic liver tumors from colorectal carcinoma was examined.
Methods: Ten patients with a total of 30 liver metastases from colorectal carcinoma were treated using a Cool-tip RF system from March 2003 to December 2004.
Results: Patients had a mean age of 69.
We evaluated the efficacy of radiofrequency ablation (RFA) therapy for 29 patients with 36 hepatocellular carcinoma (HCC) nodules and 16 patients with 38 metastatic hepatic nodules. The mean tumor size was 26.4 mm.
View Article and Find Full Text PDFA 59-year-old man was admitted to our hospital because of vomiting and body weight loss. Upper GI series and upper digestive tract endoscopy revealed type 3 cancer lesion in the area from the lower thoracic esophagus to the middle gastric body. In the biopsy specimen squamous cell cancer was shown.
View Article and Find Full Text PDFThe case was a 49-year-old woman. In 1995, she underwent Hartmann's operation for sigmoid colon carcinoma. Histological stage was IV [se, n4(+), P0, H0, M(-)].
View Article and Find Full Text PDFThe patient was a 49-year-old man. In 1995, he underwent left hemicolectomy for descending colon carcinoma, and in 1996, partial hepatic resection was performed for liver metastasis. Post-operative chemotherapy was performed with 5'-DFUR.
View Article and Find Full Text PDFWe report a case of multiple superficial esophageal cancers with liver cirrhosis successfully treated by radiotherapy. The patient was a 55-year-old man with liver cirrhosis who was under the treatment of internists at our hospital. Upper digestive tract endoscopic examination revealed multiple superficial esophageal cancers.
View Article and Find Full Text PDFThe majority of vaginal metastases from extra-genital tumors are from colorectal cancer. A case of metastases to the vagina from a huge rectal carcinoma is described. A 55-year-old woman was admitted to the hospital because of a barium ileus after upper GI.
View Article and Find Full Text PDFFive patients with inoperable advanced gastric cancer were treated with combination chemotherapy of TS-1 and cisplatin (CDDP). TS-1 of 80-120 mg/body/day was orally administered for 3 weeks followed by 2 drug-free weeks, and 60 mg/m2/day of CDDP was venally administered on Day 8. It was possible to evaluate all 5 patients for response and toxicity.
View Article and Find Full Text PDFA 64-year-old male visited our hospital with complaints of epigastric pain. Computed tomography (CT) showed gastric cancer with extensive paraaortic lymph node metastasis. We decided that a curative operation was impossible, and administered the following chemotherapy.
View Article and Find Full Text PDF